Showing results (121-130 of 165) with videos related to

Sort By:
Pageof 17
Headache|April 28, 2015
Are depressive symptomatology, self-efficacy, and perceived social support related to disability and quality of life in patients with chronic migraine associated to medication overuse? Data from a cross-sectional studyDomenico D'Amico, Licia Grazzi, Gennaro Bussone, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 17, 2013
Validating the Migraine-Specific Quality of Life Questionnaire v2.1 (MSQ) in Italian inpatients with chronic migraine with a history of medication overuseAlberto Raggi, Ambra Mara Giovannetti, Silvia Schiavolin, et al.
Journal of the Neurological Sciences|December 2, 2014
Chronic migraine with medication overuse: association between disability and quality of life measures, and impact of disease on patients' livesAlberto Raggi, Silvia Schiavolin, Matilde Leonardi, et al.
Global Advances in Health and Medicine|September 9, 2021
Online Mindfulness May Target Psychological Distress and Mental Health during COVID-19Suzan R Farris, Licia Grazzi, Miya Holley, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 21, 2017
Mindfulness and pharmacological prophylaxis have comparable effect on biomarkers of inflammation and clinical indexes in chronic migraine with medication overuse: results at 12 months after withdrawalLicia Grazzi, Domenico D'Amico, Alberto Raggi, et al.
The Journal of Headache and Pain|January 9, 2019
Correction to: Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trialLicia Grazzi, Cristina Tassorelli, Marina de Tommaso, et al.
The Journal of Headache and Pain|December 20, 2018
Correction to: Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trialPaolo Martelletti, Piero Barbanti, Licia Grazzi, et al.
The Journal of Headache and Pain|October 21, 2018
Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trialLicia Grazzi, Cristina Tassorelli, Marina de Tommaso, et al.
The Journal of Headache and Pain|November 2, 2018
Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trialPaolo Martelletti, Piero Barbanti, Licia Grazzi, et al.
Cephalalgia : an International Journal of Headache|July 28, 2010
Almotriptan 12.5 mg in menstrually related migraine: a randomized, double-blind, placebo-controlled studyGianni Allais, Gennaro Bussone, Giovanni D'Andrea, et al.
Pageof 17